DOI:
10.1039/D5RA06081H
(Paper)
RSC Adv., 2025,
15, 36485-36489
Dehydroabietyl squaramide incorporating chiral pyrrolidine for highly diastereo- and enantioselective Michael reaction between cyclohexanone and β-nitrostyrenes
Received
17th August 2025
, Accepted 26th September 2025
First published on 1st October 2025
Abstract
Through an efficient two-step synthetic strategy, we synthesized two novel dehydroabietyl pyrrolidin-2-yl squaramides, which were evaluated for their ability to catalyze the asymmetric Michael addition of cyclohexanone to β-nitrostyrenes. The (R)-pyrrolidin-2-yl substituted dehydroabietyl squaramide emerged as the superior catalyst, facilitating the asymmetric synthesis of the corresponding adducts with high yields (87–98%) and good to excellent stereoselectivity (up to >99
:
1 syn/anti ratio, 99% ee).
Introduction
The advent of asymmetric organocatalysis has revolutionized the construction of optically pure bioactive molecules and natural products,1,2 stimulating much more efforts toward catalyst innovation. Among the privileged scaffolds, chiral bifunctional dehydroabietyl thioureas (Fig. 1a) and squaramides (Fig. 1b) have demonstrated remarkable efficiency in diverse enantioselective transformations.3 These structurally cognate catalysts share a common dehydroabietyl framework integrated with a secondary chiral element, enabling stereocontrol via double hydrogen-bonding interactions. While dehydroabietyl thioureas have been thoroughly investigated, their squaramide counterparts have received comparatively less attention.
 |
| Fig. 1 Bifunctional dehydroabietyl thioureas and squaramides. | |
Since List's groundbreaking discovery of proline-catalyzed direct enantioselective Michael reactions between unactivated ketones and nitroolefins,4 diverse pyrrolidine-based catalysts have been developed for various organocatalytic asymmetric conjugate additions.5–18 Among these, pyrrolidinyl (thio)ureas and squaramides have emerged as privileged scaffolds for promoting the asymmetric Michael reaction of cyclic ketones with nitroolefins (Fig. 2a). Nevertheless, systematic exploration of pyrrolidinyl squaramide architectures is still limited.
 |
| Fig. 2 Design of dehydroabietyl pyrrolidin-2-yl squaramides. | |
Capitalizing on these advancements and our continuous investigation of dehydroabietyl-based squaramide catalysts,3 we envisioned that strategic unification of chiral dehydroabietyl and pyrrolidin-2-yl structural elements via a squaramide tether might engender novel bifunctional organocatalysts (Fig. 2b). To the best of our knowledge, this particular molecular architecture, represents uncharted territory in organocatalyst design. Herein, we disclose the catalytic efficacy of chiral pyrrolidine-embedded dehydroabietyl squaramides in the asymmetric conjugate addition of cyclohexanone to β-nitrostyrenes.
Results and discussion
Synthesis of the target dehydroabietyl squaramides
Squaramides C1 and C2 were readily synthesized from commercially available dehydroabietylamine and (R)/(S)-1-Boc-2-(aminomethyl)pyrrolidine in two steps (Scheme 1).
 |
| Scheme 1 Synthetic route for squaramides C1 and C2. | |
Asymmetric conjugate addition
We initially evaluated squaramides C1 and C2 in the model reaction of cyclohexanone 1 and nitroolefin 2a (Table 1).
Table 1 Optimization of reaction conditionsa
As shown in Table 1, squaramides C1–C3 effectively catalyzed the reaction under standard conditions (catalyst, Et3N, nPrCOOH, neat, r.t.),11 delivering the syn-adducts in high yields, with excellent diastereoselectivities and good to excellent enantioselectivities (entries 1–3). The stereochemistry of the dehydroabietyl moiety in the new squaramides demonstrated better compatibility with the (R)-pyrrolidin-2-yl moiety (entry 1 vs. 2) and a slight advantage compared to catalyst C3 bearing the 3,5-bis(trifluoromethyl)phenyl group (entry 1 vs. 3). Control experiments revealed that C1, bases, and acids are essential for the reaction, as no conversion occurred in their absence (entries 4–7). Subsequent screening of alternative Brønsted acids and other solvents failed to improve upon the standard conditions (entries 8–11). Lowering the reaction temperature significantly enhanced stereocontrol (entries 12 and 13), underscoring the key role of the dehydroabietyl framework in catalytic activity. Furthermore, reducing the catalyst loading to 5 mol% necessitated a prolonged reaction time, while high catalytic efficiency was still effectively maintained (entry 14).
Substrate scope
The optimized reaction conditions were applied to a range of β-nitrostyrenes (Table 2).
Table 2 Scope of the Michael addition by using C1a
Generally, β-nitrostyrenes with 4-, 3-, or 2-substituted phenyl groups (electron-donating/withdrawing groups) delivered high yields (90–98%), good to excellent diastereo- (up to >99
:
1 syn/anti) and excellent enantioselectivities (92–>99% ee). Substrates bearing 2-naphthyl and heterocyclic moieties (2-thienyl and 2-furyl) also showed favorable reactivity, although the 2-furyl derivatives exhibited diminished selectivity (87
:
13 dr, 78% ee). The observed decrease in stereoselectivity for the 2-furyl substrate may be attributed to the stronger tendency of oxygen atom, relative to sulfur atom in the 2-thienyl substrate, to participate in hydrogen bonding.19 The oxygen atom in the furyl ring might form additional hydrogen-bonding interactions within the catalytic environment, which could interfere with the catalyst's ability to exert stereochemical control, consequently leading to lower stereoselectivity. Moreover, the stereochemical assignments of the Michael adducts were established through comparative analysis of their NMR spectroscopic data and specific optical rotations with those of structurally characterized analogues documented in prior studies (see SI).11a,13,14,16
The asymmetric additions of other ketones to β-nitrostyrene 2a were also examined under the optimized reaction conditions. As illustrated in Scheme 2, cyclopentanone exhibited extremely poor reactivity and did not yield the desired adduct even at room temperature. Acetone afforded the desired product in an excellent yield (98%), yet with low enantioselectivity (27% ee). These findings may be rationalized by considering the distinct energy landscapes associated with the nucleophilic addition of the pyrrolidine moiety to the carbonyl group of structurally diverse ketones, which governs the kinetics of enamine generation,11a as well as the differential steric hindrance encountered during the C–C bond-forming event between the in situ-generated enamine and the nitroolefin acceptor.
 |
| Scheme 2 Conjugate additions of other ketones to 2a. | |
Scale-up synthesis
A gram-scale reaction of cyclohexanone 1 with substrate 2k using 10 mol% of catalyst C1 afforded the adduct 3k in 91% yield with excellent stereoselectivities (98
:
2 syn/anti and 95% ee), albeit with a slight decrease in selectivity (Scheme 3).
 |
| Scheme 3 Gram-scale preparation of the adduct 3k. | |
Proposed catalytic mechanism
As outlined in Scheme 4, the proposed catalytic mechanism may proceed via a cooperative bifunctional activation process facilitated by the Et3N/nPrCOOH system, according to our experimental data and literature precedents.11–16 While further studies are needed to fully understand the details, this steric control model offers a plausible explanation for the high level of stereoselectivity observed in the reaction. The pathway may follow a sequence in which: (i) the pyrrolidine moiety generates a catalytically active enamine intermediate with the carbonyl substrate; (ii) concurrently, the squaramide moiety organizes the nitroolefin electrophile and the base via well-defined H-bonding interactions; while (iii) the sterically demanding dehydroabietyl scaffold confers facial selectivity, directing the enamine attack preferentially toward the Si-face.
 |
| Scheme 4 Possible transition-state model. | |
Conclusions
In summary, we have developed a new highly efficient chiral bifunctional organocatalyst, featuring a dehydroabietyl (R)-pyrrolidin-2-yl squaramide architecture that is strategically integrated to enhance catalytic performance. The catalyst demonstrated remarkable performance in the asymmetric Michael addition of cyclohexanone to diverse β-nitrostyrenes, enabling the synthesis of valuable chiral γ-nitroketone derivatives with high efficiency (up to 98% yield) and good to excellent stereocontrol (up to >99
:
1 syn/anti and >99% ee). The versatility of this catalytic system in other asymmetric transformations, along with detailed mechanistic studies (e.g., computational modeling) is currently under investigation in our ongoing research.
Experimental section
General information
All reactions were conducted directly under ambient air unless otherwise stated. All reagents were obtained from commercial sources and used without further purification. The isolation and purification of all reaction products were carried out by column chromatography on silica gel (200–300 mesh). The reaction progress was monitored by thin-layer chromatography (TLC) using precoated silica gel 60 GF254 plates and visualized under UV light. NMR spectra were recorded by using Bruker Advance III spectrometer (500 MHz) in CDCl3 and CF3COOD. All enantiomeric excesses were determined by HPLC analysis using chiral stationary phases IA-H or AD-H in a Shimadzu LC-20AT chromatogram with hexane/2-propanol as eluent. High-resolution mass spectra were recorded using a SCIEX ESI-QTOF. The optical rotation measurements were conducted using an IP-digi 300/8 digital polarimeter, and the melting points were determined with a WRS-3 melting-point apparatus. Catalyst C3 was synthesized according to the reported synthetic procedure.12
Preperation of dehydroabietyl squaramides C1–C2
To a solution of dehydroabietylamine (2.85 g, 10 mmol) in methanol was added dimethyl squarate (1.56 g, 11 mmol), and the mixture was stirred at room temperature for 48 h. The resulting precipitate was triturated with methanol, filtered under reduced pressure and washed with methanol to afford a light pink solid, Int-1 (3.72 g, 91% yield).
To a stirred solution of (R)- or (S)-tert-butyl-2-(aminomethyl) pyrrolidine-1-carboxylate (0.1 g, 0.5 mmol) in methanol was added the intermediate Int-1 (0.22 g, 0.55 mmol) at room temperature. After 48 h, the white precipitate was filtered and dried. The collected solid was subsequently dissolved in dichloromethane, and trifluoroacetic acid (10 equiv.) was added dropwise at 0 °C. The resulting solution was stirred at room temperature for 48 h. The pH was adjusted using aqueous Na2CO3 solution. The mixture was extracted with dichloromethane (3 × 20 mL) and washed by brine. The combined extracts were dried over anhydrous Na2SO4, and purified through column chromatography on silica gel (dichloromethane/methanol = 100
:
1–10
:
1) to give the desired catalysts.
3-((((1R, 4aS, 10aR)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl)methyl)amino)-4-((((R)-pyrrolidin-2-yl)methyl)amino)cyclobut-3-ene-1,2-dione (C1). White solid, (0.152 g, 0.32 mmol, 75% yield). m.p. 203.5–204.2 °C. [α]D20 = −19.1 (c 0.5, 2% TFA in CH2Cl2). 1H NMR (500 MHz, CDCl3/CF3COOD) δ 7.17 (d, J = 8.2 Hz, 1H), 7.02 (dd, J = 8.2, 2.0 Hz, 1H), 6.90 (d, J = 2.0 Hz, 1H), 4.09–4.00 (m, 3H), 3.62–3.52 (m, 3H), 3.53–3.42 (m, 1H), 2.99–2.88 (m, 1H), 2.87–2.74 (m, 2H), 2.37–2.30 (m, 2H), 2.30–2.09 (m, 3H), 1.94–1.65 (m, 6H), 1.53–1.25 (m, 5H), 1.23 (s, 6H), 1.21 (s, 3H), 0.99 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 178.75, 178.44, 169.25, 166.01, 146.92, 146.26, 134.56, 127.13, 124.29, 61.79, 61.73, 57.01, 56.86, 47.23, 47.14, 47.06, 45.73, 38.12, 37.65, 35.61, 33.61, 29.88, 27.69, 25.30, 23.98, 23.49, 23.46, 18.92, 18.30, 17.74. HR-MS-EI (m/z): calcd for C29H41N3O2 [M–H]−: 462.3126; found: 462.3122.
3-((((1R,4aS,10aR)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl)methyl)amino)-4-((((S)-pyrrolidin-2-yl)methyl)amino)cyclobut-3-ene-1,2-dione (C2). White solid, (0.156 g, 0.34 mmol, 77% yield). m.p. 173.8–174.0 °C. [α]n20 = +16.0 (c 0.5, 1% TFA in CH2Cl2). 1H NMR (500 MHz, CDCl3/CF3COOD) δ 7.18 (d, J = 8.1 Hz, 1H), 7.03 (dd, J = 8.2, 2.1 Hz, 1H), 6.91 (d, J = 2.1 Hz, 1H), 4.17–4.01 (m, 3H), 3.68 (d, J = 13.5 Hz, 1H), 3.61–3.53 (m, 2H), 3.51–3.46 (m, 1H), 2.95 (dd, J = 17.2, 5.8 Hz, 1H), 2.90–2.75 (m, 2H), 2.42–2.30 (m, 2H), 2.30–2.03 (m, 3H), 1.90–1.68 (m, 6H), 1.55–1.26 (m, 5H), 1.23 (d, J = 5.3 Hz, 6H), 1.21 (s, 3H), 1.00 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 178.16, 178.05, 169.32, 165.75, 146.97, 146.53, 134.63, 127.24, 124.42, 62.01, 57.29, 47.36, 46.08, 45.47, 38.26, 38.21, 37.77, 35.70, 33.73, 29.91, 27.74, 25.25, 23.92, 23.90, 23.49, 19.06, 18.29, 17.58. HR-MS-EI (m/z): calcd for C29H41N3O2 [M–H]−: 462.3126; found: 462.3124.
General procedure for the catalytic asymmetric Michael addition
To a stirred solution of cyclohexanone (20 equiv.) were added triethylamine (20 mol%) and the catalyst (10 mol%) at room temperature. n-Butyric acid (10 mol%) was introduced after 30 min, and the mixture was further stirred for 15 min. Finally, β-nitroolefins (1 equiv.) were added at the designated temperature. Upon completion of the reaction, the mixture was purified by column chromatography using silica gel with a gradient elution of petroleum ether and ethyl acetate from 50
:
1 to 10
:
1, yielding the corresponding adducts.
Author contributions
Conceptualization and funding acquisition, Z.-W. Zhang and Y.-Q. Deng; writing – original draft preparation, K. Xiong and S.-W. Liu; writing – review and editing, Z.-W. Zhang and Y.-Q. Deng.
Conflicts of interest
The authors declare no competing financial interest.
Data availability
The data of NMR, HRMS and HPLC spectra of the synthesized compounds supporting this article have been included as part of the supplementary information (SI). Supplementary information: NMR and HRMS spectra of the new catalysts, and the characterization data of all adducts. See DOI: https://doi.org/10.1039/d5ra06081h.
Acknowledgements
This research was supported by Research Basic Ability Improvement Project for Middle-aged and Young Teachers of Universities in Guangxi (2025KY0385); Guangxi Natural Science Foundation (2025GXNSFBA069322, AD19245138 and 2020GXNSFAA297215); Guangxi University of Chinese Medicine ‘Qihuang Project’ High-level Talent Team Cultivation Programme (202408).
References
- B. Han, X.-H. He, Y.-Q. Liu, G. He, C. Peng and J.-L. Li, Chem. Soc. Rev., 2021, 50, 1522–1586 RSC.
- M. Rénioa and M. R. Ventura, Org. Biomol. Chem., 2025, 23, 7521–7537 RSC.
- Z.-W. Zhang, S.-W. Liu, H.-P. Huang, Y.-H. Xie, R.-C. Huang, Y.-Q. Deng and N. Lin, RSC Adv., 2023, 13, 31047–31058 RSC.
- B. List, P. Pojarliev and H. J. Martin, Org. Lett., 2001, 3, 2423–2425 CrossRef CAS PubMed.
- Ł. Albrecht, H. Jiang and K. A. Jørgensen, Chem.–Eur. J., 2014, 20, 358–368 CrossRef PubMed.
- D. A. Alonso, A. Baeza, R. Chinchilla, C. Gómez, G. Guillena, I. M. Pastor and D. J. Ramón, Molecules, 2017, 22, 895 CrossRef PubMed.
- T. Das, S. Mohapatra, N. P. Mishra, S. Nayak and B. P. Raiguru, ChemistrySelect, 2021, 6, 3745–3781 CrossRef CAS.
- S. D. Pasuparthy and B. Maiti, ChemistrySelect, 2022, 7, e202104261 CrossRef CAS.
- A. Quintavalla, D. Carboni and M. Lombardo, Molecules, 2023, 28, 2234 CrossRef CAS PubMed.
- E. Reyes, L. Prieto, U. Uria, L. Carrillo and J. L. Vicario, Catalysts, 2023, 13, 1091 CrossRef CAS.
-
(a) A. Lu, P. Gao, Y. Wu, Y. Wang, Z. Zhou and C. Tang, Org. Biomol. Chem., 2009, 7, 3141–3147 RSC;
(b) A. Lu, R. Wu, Y. Wang, Z. Zhou, G. Wu, J. Fang and C. Tang, Eur. J. Org Chem., 2011, 2011, 122–127 CrossRef.
- Ł. Albrecht, F. C. Acosta, A. Fraile, A. Albrecht, J. Christensen and K. A. Jørgensen, Angew. Chem., Int. Ed., 2012, 51, 9088–9092 CrossRef PubMed.
- A. Ruiz-Olalla, M. de G. Retamosa and F. P. Cossío, J. Org. Chem., 2015, 80, 5588–5599 CrossRef CAS PubMed.
- J. H. Shim, B. K. Ahn, J. Y. Lee, H. S. Kim and D.-C. Ha, Catalysts, 2021, 11, 1004 CrossRef CAS.
- D. Bae, J. W. Lee and D. H. Ryu, J. Org. Chem., 2022, 87, 16532–16541 CrossRef CAS PubMed.
- D. Rani, M. Khera, N. Goel and J. Agarwal, Mol. Catal., 2023, 545, 113185 CAS.
- Y.-X. Liu, Y.-Y. Xu, S. Li, Z.-Q. Pan, B.-X. Li and Z.-Y. Fan, Lett. Org. Chem., 2024, 21, 149–154 CrossRef CAS.
- Y. Liu, Z. Fan, Q. Liu, M. Lv and X. Dai, Russ. J. Org. Chem., 2025, 61, 484–491 CrossRef CAS.
- A. T. Balaban, D. C. Oniciu and A. R. Katritzky, Chem. Rev., 2004, 104, 2777–2812 CrossRef CAS PubMed.
Footnote |
† These two authors contributed equally. |
|
This journal is © The Royal Society of Chemistry 2025 |
Click here to see how this site uses Cookies. View our privacy policy here.